Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00033345 | Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer | completed | Phase 1 | 17 | University of Kansas Medical CenterOTHER | 1 | Aug 18, 2016 | clinicaltrials |
| NCT01045421 | Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies | completed | Phase 1 / Phase 2 | 273 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Aug 15, 2016 |
| clinicaltrials |
| NCT00588640 | Study of D-Methadone in Patients With Chronic Pain | completed | Phase 1 / Phase 2 | 10 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 10, 2016 | clinicaltrials |
| NCT01248494 | PhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breast Cancer | completed | Phase 1 | 72 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jul 25, 2016 | clinicaltrials |
| NCT02418481 | Safety and Efficiency of γδ T Cell Against Breast Cancer(Her-, er-, and pr-) | completed | Phase 1 / Phase 2 | 40 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jul 19, 2016 | clinicaltrials |
| NCT00450892 | Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer | completed | Phase 1 / Phase 2 | 129 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 7, 2016 | clinicaltrials |
| NCT00951665 | A Study of Trastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 107 | Genentech, Inc.INDUSTRY | 1 | Jun 24, 2016 | clinicaltrials |
| NCT01155258 | Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 19 | University of Southern CaliforniaOTHER | 1 | Jun 13, 2016 | clinicaltrials |
| NCT01042925 | Study of XL147 (SAR245408) in Combination With Trastuzumab or Paclitaxel and Trastuzumab in Subjects With Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-based Regimen | completed | Phase 1 / Phase 2 | 42 | SanofiINDUSTRY | 2 | Jun 3, 2016 | clinicaltrials |
| NCT01082068 | Study of XL147 (SAR245408) or XL765 (SAR245409) in Combination With Letrozole in Subjects With Breast Cancer | completed | Phase 1 / Phase 2 | 72 | SanofiINDUSTRY | 3 | Jun 3, 2016 | clinicaltrials |
| NCT00327743 | Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 34 | SanofiINDUSTRY | 2 | May 18, 2016 | clinicaltrials |
| NCT00574366 | Erlotinib and Everolimus in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 | 14 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | May 10, 2016 | clinicaltrials |
| NCT01288261 | Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer | completed | Phase 1 | 14 | University of ArizonaOTHER | 1 | Apr 21, 2016 | clinicaltrials |
| NCT01459172 | Human Breast Tissue Bioavailability of Topically Applied Limonene | completed | Phase 1 | 103 | University of ArizonaOTHER | 1 | Apr 21, 2016 | clinicaltrials |
| NCT01276496 | Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery | completed | Phase 1 | 13 | National Cancer Institute (NCI)NIH | 1 | Mar 15, 2016 | clinicaltrials |
| NCT00012129 | Chemotherapy in Treating Patients With Breast Cancer | completed | Phase 1 / Phase 2 | — | NYU Langone HealthOTHER | 1 | Mar 11, 2016 | clinicaltrials |
| NCT00182767 | Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer | completed | Phase 1 / Phase 2 | 45 | National Cancer Institute (NCI)NIH | 1 | Mar 10, 2016 | clinicaltrials |
| NCT00322374 | Phase I Combination w/ Epirubicin | completed | Phase 1 | 42 | R-PharmINDUSTRY | 2 | Mar 10, 2016 | clinicaltrials |
| NCT00568022 | A Phase I Study of Ixabepilone in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer | completed | Phase 1 | 9 | R-PharmINDUSTRY | 1 | Mar 10, 2016 | clinicaltrials |
| NCT00508586 | PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer | completed | Phase 1 | 33 | PTC TherapeuticsINDUSTRY | 1 | Mar 3, 2016 | clinicaltrials |
| NCT02523417 | HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Breast Cancer | completed | Phase 1 / Phase 2 | 15 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Feb 25, 2016 | clinicaltrials |
| NCT00247013 | Automated Tele Counseling for Screening Mammography | completed | Phase 1 | 2,120 | Boston Medical CenterOTHER | 1 | Feb 22, 2016 | clinicaltrials |
| NCT00933309 | The Impact of Obesity and Obesity Treatments on Breast Cancer | completed | Phase 1 | 25 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 19, 2016 | clinicaltrials |
| NCT00027807 | Biological Therapy in Treating Women With Stage IV Breast Cancer | completed | Phase 1 | 6 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Feb 17, 2016 | clinicaltrials |
| NCT00753207 | Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30 | completed | Phase 1 | 10 | Cancer Trials IrelandNETWORK | 1 | Feb 15, 2016 | clinicaltrials |
| NCT02020291 | Phase I Study to Evaluate Safety, Tolerability, Anti-Tumour Activity and PK Profiles of Foxy-5 in Metastatic Breast, Colon or Prostate Cancer | completed | Phase 1 | 31 | WntResearch ABINDUSTRY | 1 | Feb 2, 2016 | clinicaltrials |
| NCT01018108 | Visualization of the Effect of Acupuncture on Brain Serotonin in Breast Cancer Survivors | completed | Phase 1 | 7 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jan 26, 2016 | clinicaltrials |
| NCT00468585 | Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model | completed | Phase 1 / Phase 2 | 62 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 22, 2016 | clinicaltrials |
| NCT00900627 | Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II)(THYME) | completed | Phase 1 / Phase 2 | 330 | AstraZenecaINDUSTRY | 14 | Jan 20, 2016 | clinicaltrials |
| NCT01502592 | Pre-Operative, Single-Dose Ipilimumab and/or Cryoablation in Early Stage/Resectable Breast Cancer | completed | Phase 1 | 19 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 5, 2016 | clinicaltrials |
| NCT00426556 | Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer | completed | Phase 1 | 88 | Novartis PharmaceuticalsINDUSTRY | 5 | Dec 28, 2015 | clinicaltrials |
| NCT00574977 | Safety Study of Modified Vaccinia Virus to Cancer | completed | Phase 1 | 26 | David BartlettOTHER | 1 | Dec 28, 2015 | clinicaltrials |
| NCT00581815 | Spectroscopy With Surface Coils and Decoupling | completed | Phase 1 | 582 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 28, 2015 | clinicaltrials |
| NCT00605397 | PET Imaging With Cu-64 Labeled Trastuzumab in HER2+ Metastatic Breast Cancer(Cu-64 HER2+) | completed | Phase 1 | 11 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 28, 2015 | clinicaltrials |
| NCT00039286 | Positron Emission Tomography Before Surgery in Evaluating Women With Primary or Recurrent Breast Cancer | completed | Phase 1 | 118 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 24, 2015 | clinicaltrials |
| NCT00109785 | PET Scans in Patients With Locally Advanced Breast Cancer | completed | Phase 1 | 8 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 24, 2015 | clinicaltrials |
| NCT00588003 | Gene Expression Following Short Term Exposure to Neoadjuvant Endocrine Therapy in Invasive Breast Cancer | completed | Phase 1 | 45 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 24, 2015 | clinicaltrials |
| NCT00732056 | A Study of GRN163L With Paclitaxel and Bevacizumab to Treat Patients With Locally Recurrent Or Metastatic Breast Cancer | completed | Phase 1 | 24 | Geron CorporationINDUSTRY | 1 | Dec 24, 2015 | clinicaltrials |
| NCT00968409 | Assessment of Progesterone Receptors in Breast Carcinoma by Positron Emission Tomography (PET) Using Fluoro Furanyl Norprogesterone (FFNP)(FFNP) | completed | Phase 1 | 20 | Washington University School of MedicineOTHER | 1 | Dec 9, 2015 | clinicaltrials |
| NCT01626066 | Cathepsin Activatable Fluorescent Probe(LUM015) | completed | Phase 1 | 15 | David KirschOTHER | 1 | Dec 9, 2015 | clinicaltrials |
| NCT01172028 | Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 33 | University of ArizonaOTHER | 1 | Dec 3, 2015 | clinicaltrials |
| NCT00571987 | Pilot Study of Radiofrequency Ablation of Breast Cancer Lumpectomy Sites to Decrease Re-operation(eRFA) | completed | Phase 1 / Phase 2 | 107 | University of ArkansasOTHER | 1 | Nov 24, 2015 | clinicaltrials |
| NCT00368875 | Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 54 | National Cancer Institute (NCI)NIH | 1 | Nov 5, 2015 | clinicaltrials |
| NCT00773344 | Clinical Trial of the Combination of Trastuzumab (Herceptin) and Tanespimycin in Patients With Solid Tumors and Her2 Positive Metastatic Breast Cancer That Have Previously Failed Herceptin | completed | Phase 1 / Phase 2 | 25 | Bristol-Myers SquibbINDUSTRY | 1 | Nov 4, 2015 | clinicaltrials |
| NCT00276536 | Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma(IFNa) | completed | Phase 1 | 35 | The Cleveland ClinicOTHER | 1 | Oct 14, 2015 | clinicaltrials |
| NCT00095706 | Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF) | completed | Phase 1 / Phase 2 | 50 | Translational Oncology Research InternationalOTHER | 1 | Sep 25, 2015 | clinicaltrials |
| NCT00932373 | A Study of Trastuzumab-MCC-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer Who Have Previously Received a Trastuzumab-Containing Regimen | completed | Phase 1 | 54 | Genentech, Inc.INDUSTRY | 0 | Aug 26, 2015 | clinicaltrials |
| NCT02437539 | Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography(uPAR-PET) | completed | Phase 1 | 10 | Rigshospitalet, DenmarkOTHER | 1 | Aug 24, 2015 | clinicaltrials |
| NCT00425776 | Treatment of Hot Flushes in Breast Cancer Patients With Acupuncture | completed | Phase 1 | 94 | Vejle HospitalOTHER | 1 | Aug 21, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Aug 18, 2016source: clinicaltrials